The UK’s National Health Service (NHS) East of England has contracted Radisens Diagnostics Ltd, a medical diagnostics start-up developing a highly integrated point-of-care blood analyser platform, to integrate a creatinine (kidney) test onto it’s existing chronic care assay panel for long-term disease management.
Supported by NHS East of England, the European Regional Development Fund and the Technology Strategy Board, the East of England Small Business Research Initiative is looking to industry to commercialise innovation that can be shown to make a difference to the care of people with long-term conditions.
Administered by Health Enterprise East (HEE), the NHS innovation partner organisation for the East of England, this builds upon the outcomes from the NHS East’s Working Group to review the productivity opportunities and health economic benefits offered by utilising appropriate diagnostic tests in community settings.
Karen Livingstone, Director of Strategic Partnerships at NHS East of England said: “It is estimated that around one in three people are living with a long-term condition which not only creates real personal challenges, but also increases the cost of healthcare. New technologies will mean that in the future, more people will be able to receive treatment in their own homes, with their condition monitored and managed without having to visit or stay in a hospital. This not only makes for an improved patient experience but also saves healthcare resources and costs which currently amount to £7 out of every £10 being spent on long-term conditions.”
Radisens Diagnostics has the only point-of-care platform to integrate immunoassay, biochemistry and haematology tests onto a single mini-disc panel, to diagnose and monitor patients for multiple chronic and acute care conditions. This project targets the integration of a creatinine (kidney) test on to Radisens’ lon-term chronic care panel. Using a finger-prick of blood applied to the panel, the Radisens diagnostic device returns results within minutes. This chronic care panel will enable the GP to actively monitor long-term chronic disease patients for diabetes, heart disease, hypertension and chronic kidney disease, resulting in better patient care and significant productivity gains and efficiences in the healthcare system.
Jerry O’Brien, Radisens Diagnostics’ CEO said: “We are delighted to be working with the NHS in the East of England to deliver on their visionary requirements for testing of long-term chronic care conditions. Decentralising the long-term disease management to point of care, leads to significantly improved patient care, and productivity gains and efficiencies within the healthcare system”
About Radisens Diagnostics
Radisens Diagnostics develops disruptive point-of-care diagnostic platforms and multiplexed test panels, which diagnose and monitor patients for multiple chronic and acute care conditions. This is the only point-of-care platform to integrate immunoassay, biochemistry and cellular haematology onto a single test panel. Using a finger-prick of blood, the analyser returns laboratory-grade results in the doctor’s office within minutes. With offices in Cork, Ireland and Boston, Massachusetts, Radisens Diagnostics is a convergence of medical diagnostics and consumer electronics using disruptive patent pending technology to deliver on the significant market and clinical need for decentralising diagnostics into point of care settings such as doctor’s offices, outpatient and emergency room departments, intensive care units and hospital bedsides.
About Health Enterprise East
Health Enterprise East Limited (HEE) is the NHS partner organisation for Innovation. HEE is committed to improving healthcare through supporting the development of innovative new products and services which meet the needs of the NHS. HEE provides a broad range of services to NHS organisations, providing expert advice, funding and support to NHS innovators to translate their ideas into practice. Operating within the NHS, HEE also provides consultancy services to technology based companies looking to access the UK market. HEE works with clinical key opinion leaders and senior NHS managerial, commissioning and procurement staff on a daily basis. Our NHS market assessments provide vital information for companies to ensure that their products are well targeted to the technical and business needs of the NHS, speeding up adoption of new technology by the NHS. Health Enterprise East is based at Papworth Hospital Cambridge, one of the leading UK Cardio/Respiratory Research and Treatment Centres.
